Encavis (ETR:CAP) received a €7.80 ($9.63) price target from investment analysts at Baader Bank in a research note issued on Thursday. The brokerage currently has a “buy” rating on the stock. Baader Bank’s price target would indicate a potential upside of 18.90% from the stock’s previous close.
A number of other analysts also recently weighed in on CAP. DZ Bank restated a “buy” rating on shares of Encavis in a report on Wednesday, January 17th. Oddo Bhf set a €7.15 ($8.83) target price on shares of Encavis and gave the stock a “buy” rating in a report on Friday, February 23rd. Five analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and a consensus price target of €7.99 ($9.86).
Encavis stock opened at €6.56 ($8.10) on Thursday. Encavis has a twelve month low of €5.85 ($7.22) and a twelve month high of €7.15 ($8.83).
TRADEMARK VIOLATION WARNING: This news story was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/04/07/encavis-cap-pt-set-at-7-80-by-baader-bank.html.
Encavis AG, formerly Capital Stage AG, is a Germany-based producer of electricity from renewable energy sources. The Company invests in solar and wind parks, which it also operates. The Company divides its activities into four segments: Solar Parks, which is engaged in acquisition and operation of ground mounted photovoltaic (PV) parks; Wind Parks, engaged in acquisition and operation of onshore wind parks; Institutional Clients, which, through Encavis Asset Management AG, offers customized portfolios or fund solutions for investments in renewable energies, and Technical Services, responsible for technical operation and maintenance of PV parks.
Receive News & Ratings for Encavis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encavis and related companies with MarketBeat.com's FREE daily email newsletter.